<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<p:sld xmlns:a="http://schemas.openxmlformats.org/drawingml/2006/main" xmlns:r="http://schemas.openxmlformats.org/officeDocument/2006/relationships" xmlns:p="http://schemas.openxmlformats.org/presentationml/2006/main"><p:cSld><p:spTree><p:nvGrpSpPr><p:cNvPr id="1" name=""/><p:cNvGrpSpPr/><p:nvPr/></p:nvGrpSpPr><p:grpSpPr><a:xfrm><a:off x="0" y="0"/><a:ext cx="0" cy="0"/><a:chOff x="0" y="0"/><a:chExt cx="0" cy="0"/></a:xfrm></p:grpSpPr><p:sp><p:nvSpPr><p:cNvPr id="45057" name="Title 1"/><p:cNvSpPr><a:spLocks noGrp="1"/></p:cNvSpPr><p:nvPr><p:ph type="title"/></p:nvPr></p:nvSpPr><p:spPr><a:xfrm><a:off x="457200" y="274638"/><a:ext cx="8229600" cy="792162"/></a:xfrm></p:spPr><p:txBody><a:bodyPr/><a:lstStyle/><a:p><a:r><a:rPr lang="en-US" smtClean="0"/><a:t>Project ImPACT: Hyperlipidemia</a:t></a:r></a:p></p:txBody></p:sp><p:sp><p:nvSpPr><p:cNvPr id="3" name="Content Placeholder 2"/><p:cNvSpPr><a:spLocks noGrp="1"/></p:cNvSpPr><p:nvPr><p:ph idx="1"/></p:nvPr></p:nvSpPr><p:spPr><a:xfrm><a:off x="304800" y="1143000"/><a:ext cx="8534400" cy="5257800"/></a:xfrm></p:spPr><p:txBody><a:bodyPr rtlCol="0"><a:normAutofit fontScale="70000" lnSpcReduction="20000"/></a:bodyPr><a:lstStyle/><a:p><a:pPr fontAlgn="auto"><a:spcAft><a:spcPts val="0"/></a:spcAft><a:buFont typeface="Arial" pitchFamily="34" charset="0"/><a:buChar char="•"/><a:defRPr/></a:pPr><a:r><a:rPr lang="en-US" dirty="0" smtClean="0"/><a:t>This study aims to demonstrate that pharmacists, working collaboratively with patients and physicians, can promote patient persistence and compliance with prescribed </a:t></a:r><a:r><a:rPr lang="en-US" dirty="0" err="1" smtClean="0"/><a:t>dyslipidemic</a:t></a:r><a:r><a:rPr lang="en-US" dirty="0" smtClean="0"/><a:t> therapy that enables patients to achieve their National Cholesterol Education Program (NCEP) goals</a:t></a:r></a:p><a:p><a:pPr fontAlgn="auto"><a:spcAft><a:spcPts val="0"/></a:spcAft><a:buFont typeface="Arial" pitchFamily="34" charset="0"/><a:buChar char="•"/><a:defRPr/></a:pPr><a:r><a:rPr lang="en-US" dirty="0" smtClean="0"/><a:t>The study utilized 26 community-based ambulatory care pharmacy practices and nearly 400 patients for an average of 24 months per patient to evaluate rates of patient persistence and compliance with medication therapy and achievement of target therapeutic goals</a:t></a:r></a:p><a:p><a:pPr fontAlgn="auto"><a:spcAft><a:spcPts val="0"/></a:spcAft><a:buFont typeface="Arial" pitchFamily="34" charset="0"/><a:buChar char="•"/><a:defRPr/></a:pPr><a:r><a:rPr lang="en-US" dirty="0" smtClean="0"/><a:t>As a result of this initiative, persistence and compliance with medication therapy were 93.6% and 90.1%, respectively, and 62.5% of patients had reached and were maintained at their NCEP lipid goal at the end of the project</a:t></a:r></a:p><a:p><a:pPr fontAlgn="auto"><a:spcAft><a:spcPts val="0"/></a:spcAft><a:buFont typeface="Arial" pitchFamily="34" charset="0"/><a:buChar char="•"/><a:defRPr/></a:pPr><a:r><a:rPr lang="en-US" dirty="0" smtClean="0"/><a:t>The study concluded that working collaboratively with patients, physicians, and other health care providers, pharmacists can provide an advanced level of care that results in successful management of </a:t></a:r><a:r><a:rPr lang="en-US" dirty="0" err="1" smtClean="0"/><a:t>dyslipidemia</a:t></a:r><a:endParaRPr lang="en-US" dirty="0" smtClean="0"/></a:p><a:p><a:pPr fontAlgn="auto"><a:spcAft><a:spcPts val="0"/></a:spcAft><a:buFont typeface="Arial" pitchFamily="34" charset="0"/><a:buChar char="•"/><a:defRPr/></a:pPr><a:endParaRPr lang="en-US" dirty="0"/></a:p></p:txBody></p:sp><p:sp><p:nvSpPr><p:cNvPr id="4" name="Footer Placeholder 3"/><p:cNvSpPr><a:spLocks noGrp="1"/></p:cNvSpPr><p:nvPr><p:ph type="ftr" sz="quarter" idx="11"/></p:nvPr></p:nvSpPr><p:spPr><a:xfrm><a:off x="0" y="6356350"/><a:ext cx="9144000" cy="501650"/></a:xfrm></p:spPr><p:txBody><a:bodyPr/><a:lstStyle/><a:p><a:pPr><a:defRPr/></a:pPr><a:r><a:rPr lang="en-US" dirty="0"/><a:t>Blum BM, </a:t></a:r><a:r><a:rPr lang="en-US" dirty="0" err="1"/><a:t>Cziraky</a:t></a:r><a:r><a:rPr lang="en-US" dirty="0"/><a:t> MJ, </a:t></a:r><a:r><a:rPr lang="en-US" dirty="0" err="1"/><a:t>McKenney</a:t></a:r><a:r><a:rPr lang="en-US" dirty="0"/><a:t> JM.  Pharmaceutical Care Services and Results in Project Impact: </a:t></a:r><a:r><a:rPr lang="en-US" dirty="0" err="1"/><a:t>Hyperlipidemia</a:t></a:r><a:r><a:rPr lang="en-US" dirty="0"/><a:t>.  </a:t></a:r><a:r><a:rPr lang="en-US" i="1" dirty="0"/><a:t>J Am </a:t></a:r><a:r><a:rPr lang="en-US" i="1" dirty="0" err="1"/><a:t>Pharm</a:t></a:r><a:r><a:rPr lang="en-US" i="1" dirty="0"/><a:t> Assoc. 200;40:157-65. http://www.pharmacist.com/AM/Template.cfm?Section=Project_ImPACT&amp;Template=/CM/</a:t></a:r></a:p><a:p><a:pPr><a:defRPr/></a:pPr><a:r><a:rPr lang="en-US" i="1" dirty="0" err="1"/><a:t>ContentDisplay.cfm&amp;ContentID</a:t></a:r><a:r><a:rPr lang="en-US" i="1" dirty="0"/><a:t>=21487.</a:t></a:r></a:p><a:p><a:pPr><a:defRPr/></a:pPr><a:endParaRPr lang="en-US" dirty="0"/></a:p><a:p><a:pPr><a:defRPr/></a:pPr><a:endParaRPr lang="en-US" dirty="0"/></a:p></p:txBody></p:sp></p:spTree><p:custDataLst><p:tags r:id="rId1"/></p:custDataLst><p:extLst><p:ext uri="{BB962C8B-B14F-4D97-AF65-F5344CB8AC3E}"><p14:creationId xmlns:p14="http://schemas.microsoft.com/office/powerpoint/2010/main" xmlns="" val="2007654606"/></p:ext></p:extLst></p:cSld><p:clrMapOvr><a:masterClrMapping/></p:clrMapOvr><p:timing><p:tnLst><p:par><p:cTn id="1" dur="indefinite" restart="never" nodeType="tmRoot"/></p:par></p:tnLst></p:timing></p:sld>